MIT has developed a new technology which, it is suggested, could make it easier to diagnose lung cancer. PATROL, a point-of-care aerosolizable nanosensor with tumor-responsive oligonucleotide barcodes, works by having patients inhale DNA-barcoded nanosensors, they then take a urine test to detect synthetic DNA reporter molecules which indicate the presence of specific lung cancer-related proteins. If successful, PATROL could supplement or replace the current standard for diagnosing lung cancer, a low-dose computed tomography, especially in low- and middle-income countries where such equipment is not always available.
‘Amber alert’ as NHS in Plymouth makes urgent plea for people with certain blood type
The NHS has issued an urgent call for O type blood donors, following increased demand after the recent cyber attack. The attack led to reduced
